Robert A. Durham

2.1k total citations
22 papers, 1.8k citations indexed

About

Robert A. Durham is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert A. Durham has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Robert A. Durham's work include Alzheimer's disease research and treatments (11 papers), Prion Diseases and Protein Misfolding (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Robert A. Durham is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Prion Diseases and Protein Misfolding (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Robert A. Durham collaborates with scholars based in United States, Puerto Rico and Japan. Robert A. Durham's co-authors include Michael J. Callahan, Feng Bian, Lary C. Walker, William J. Lipinski, John E. Smialek, Kymberly A. Gyure, Walter F. Stewart, Juan C. Troncoso, Alex E. Roher and Michael D. Kane and has published in prestigious journals such as Journal of Neuroscience, Analytical Biochemistry and Brain Research.

In The Last Decade

Robert A. Durham

22 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Durham United States 17 1.3k 772 373 336 283 22 1.8k
Alberto Pérez‐Mediavilla Spain 20 795 0.6× 834 1.1× 448 1.2× 248 0.7× 228 0.8× 39 1.7k
Tatsuhide Kunishita Japan 21 677 0.5× 769 1.0× 296 0.8× 230 0.7× 163 0.6× 50 1.9k
Gideon M. Shaked United States 12 694 0.6× 822 1.1× 568 1.5× 368 1.1× 180 0.6× 13 1.6k
Janusz Frackowiak United States 21 888 0.7× 462 0.6× 164 0.4× 322 1.0× 91 0.3× 43 1.3k
S Hirai Japan 28 1.3k 1.0× 914 1.2× 463 1.2× 407 1.2× 161 0.6× 64 2.3k
Martín A. Bruno Canada 17 608 0.5× 707 0.9× 705 1.9× 296 0.9× 187 0.7× 23 1.7k
M M Esiri United Kingdom 19 516 0.4× 573 0.7× 495 1.3× 360 1.1× 361 1.3× 42 1.9k
Jiro Takano Japan 22 1.2k 1.0× 1.1k 1.5× 766 2.1× 479 1.4× 277 1.0× 26 2.5k
Alicia Rubio Spain 21 556 0.4× 691 0.9× 484 1.3× 322 1.0× 113 0.4× 41 1.6k
A. Défossez France 18 713 0.6× 518 0.7× 169 0.5× 222 0.7× 98 0.3× 49 1.3k

Countries citing papers authored by Robert A. Durham

Since Specialization
Citations

This map shows the geographic impact of Robert A. Durham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Durham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Durham more than expected).

Fields of papers citing papers by Robert A. Durham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Durham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Durham. The network helps show where Robert A. Durham may publish in the future.

Co-authorship network of co-authors of Robert A. Durham

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Durham. A scholar is included among the top collaborators of Robert A. Durham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Durham. Robert A. Durham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraser, Stephanie, et al.. (2014). Active glucagon-like peptide 1 quantitation in human plasma: A comparison of multiple ligand binding assay platforms. Journal of Immunological Methods. 407. 76–81. 6 indexed citations
2.
Wood, Kathleen M., James J. Conboy, Robert A. Durham, et al.. (2010). P1‐459: IP/MS analysis of human CSF Aβ following a single dose of the C‐terminal anti‐Aβ antibody ponezumab (PF‐04360365) to Alzheimer patients. Alzheimer s & Dementia. 6(4S_Part_10). 5 indexed citations
3.
Conboy, James J., et al.. (2008). Modification of amyloid-β(1–40) by a protease inhibitor creates risk of error in mass spectrometric quantitation of amyloid-β(1–42). Analytical Biochemistry. 382(2). 147–149. 4 indexed citations
4.
Batliwalla, Franak, Wentian Li, Christopher T. Ritchlin, et al.. (2005). Microarray Analyses of Peripheral Blood Cells Identifies Unique Gene Expression Signature in Psoriatic Arthritis. Molecular Medicine. 11(1-12). 21–29. 103 indexed citations
5.
Cataldo, Anne M., Suzana Petanceska, Corrinne M. Peterhoff, et al.. (2004). Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome. Neurobiology of Aging. 25(10). 1263–1272. 294 indexed citations
6.
Beach, Thomas G., David Walker, Sue Li, et al.. (2003). Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease. 3(1). 57–75. 18 indexed citations
7.
Walker, Lary C., Michael J. Callahan, Feng Bian, et al.. (2002). Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice. Peptides. 23(7). 1241–1247. 71 indexed citations
8.
Walker, Lary C., Feng Bian, Michael J. Callahan, et al.. (2002). Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key?. Amino Acids. 23(1-3). 87–93. 26 indexed citations
9.
Callahan, Michael J., et al.. (2001). Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice. American Journal Of Pathology. 158(3). 1173–1177. 234 indexed citations
10.
Gyure, Kymberly A., Robert A. Durham, Walter F. Stewart, John E. Smialek, & Juan C. Troncoso. (2001). Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.. Archives of Pathology & Laboratory Medicine. 125(4). 489–92. 233 indexed citations
11.
Roher, Alex E., Yu‐Min Kuo, Pamela E. Potter, et al.. (2000). Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition. Annals of the New York Academy of Sciences. 903(1). 366–373. 47 indexed citations
12.
Beach, Thomas G., Pamela E. Potter, Yu‐Min Kuo, et al.. (2000). Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition. Neuroscience Letters. 283(1). 9–12. 53 indexed citations
13.
Cataldo, Anne M., Ralph A. Nixon, Juan C. Troncoso, et al.. (2000). Endocytic alterations in human preclinical AD and a trisomic mouse model of down syndrome: Implications for β-amyloidogenesis. Neurobiology of Aging. 21. 65–65. 1 indexed citations
14.
Durham, Robert A., John D. Johnson, Misty J. Eaton, Kenneth E. Moore, & Keith J. Lookingland. (1998). Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons. European Journal of Pharmacology. 355(2-3). 141–147. 12 indexed citations
15.
Durham, Robert A., Misty J. Eaton, Kenneth E. Moore, & Keith J. Lookingland. (1997). Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons. European Journal of Pharmacology. 335(1). 37–42. 30 indexed citations
16.
17.
Manzanares, Jorge, Robert A. Durham, Keith J. Lookingland, & Kenneth E. Moore. (1993). δ-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat. European Journal of Pharmacology. 249(1-2). 107–112. 21 indexed citations
18.
Watanabe, Kiyotaka, Atsuko Igarashi, Toyohiko Noso, et al.. (1992). Chemical identification of catfish growth hormone and prolactin.. PubMed. 1(3). 239–49. 16 indexed citations
19.
Sawyer, Donald C., et al.. (1991). Dose response to butorphanol administered subcutaneously to increase visceral nociceptive threshold in dogs. American Journal of Veterinary Research. 52(11). 1826–1830. 47 indexed citations
20.
Rech, Richard H., et al.. (1991). Dose-Response of Intravenous Butorphanol to Increase Visceral Nociceptive Threshold in Dogs. Experimental Biology and Medicine. 197(3). 290–296. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Pérez‐Mediavilla Breakdown of academic impact, for papers by Tatsuhide Kunishita Breakdown of academic impact, for papers by Gideon M. Shaked Breakdown of academic impact, for papers by Janusz Frackowiak Breakdown of academic impact, for papers by S Hirai Breakdown of academic impact, for papers by Martín A. Bruno Breakdown of academic impact, for papers by M M Esiri Breakdown of academic impact, for papers by Jiro Takano Breakdown of academic impact, for papers by Alicia Rubio Breakdown of academic impact, for papers by A. Défossez
Rankless by CCL
2026